In 2008, the combined U.S. market for dental bone graft substitutes and other biomaterials was valued at just under $200 million. This market includes bone graft substitutes, tissue engineering products, and dental membranes. The market is expected to grow rapidly as the number of bone graft procedures associated with dental implants rises.
